Latest News for Nano Magic Stock (OTC:NMGX)

Nano Magic Inc is engaged in the marketing and sale of products enabled by nanotechnology. It develops and sells products based on its portfolio of intellectual property and its products include a portfolio of nano-layer coatings, nano-based cleaners, printable inks, pastes, and thermal management materials. Its products can be used on eyeglasses, extreme sport and safety glasses and goggles, electronic screens, windows, mirrors, shower doors, and cleaning everyday household surfaces. The Majority of revenue is from the united states.

Nano Magic Inc

<ul>
<li>Seasoned accounting executive adds public company experience to Mobile Infrastructure's leadership team as Chief Financial Officer</li>
<li>Stephanie Hogue will remain in her current role as President and Director</li>
</ul>
Mobile Infrastructure Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#NYSE">BEEP</a>) ("Mobile," "Mobile Infrastructure," or the "Company"), one of the largest institutional-quality, mobility-focused parking asset owners in the U.S. today announced the appointment of Paul Gohr as Chief Financial Officer ("CFO"), effective May 16, 2024. Mr. Gohr takes on the CFO responsibility from Stephanie Hogue, who will remain in her role as President and a member of the Board of Directors.

News

Management

Mobile Infrastructure Corporation Common Stock

BEEP

Mobile Infrastructure Names  Paul Gohr As New CFO, Effective May 16, 2024, Succeeding Stephanie Hogue, Who Will Remain In Her Role As President And A Member Of The Board Of Directors

Hedge Funds

General

ORCL

13F Shows Appaloosa LP Increased Stake in Oracle Corp by 975K Shares, or +74%, to 2.3M Shares, Valued at $288.90M

Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 13.33 percent.

Earnings

Earnings Misses

RZLT

Rezolute Q3 2024 GAAP EPS $(0.34) Misses $(0.30) Estimate

BABA

13F Shows Appaloosa LP Increased Stake in Alibaba Group Hldg Ltd by 6.9M Shares, or +159%, to 11.25M Shares, Valued at $814.05M

Cryptocurrency markets are trading higher following positive news from the latest consumer <a href="https://www.benzinga.com/markets/equities/24/05/38842603/us-inflation-falls-as-expected-in-april-bolsters-fed-rate-cut-bets">price inflation data</a>.
What Happened: Major cryptocurrencies are trading higher at the time of writing:
Prices as of 4 p.m. Eastern Time:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$65,883.69</td>
<td>+7%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,020.12</td>
<td>+4.4%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$155.14&nbsp;&nbsp;</td>
<td>+8%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.154</td>
<td>+5.1%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002428</td>
<td>+3.8%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>Despite Bitcoin spiking, IntoTheBlock data shows a fall of 10.4% and 6% in large transaction volume and daily active addresses. Holders making a profit at current levels rose to 92% from 90% in a single day.  </li>
<li>Coinglass data notes Bitcoin&#8217;s total short liquidations increasing to $38.9 million, the highest since March 3. Open interest surged 8.6% to $32.1 billion.</li>
<li>Andrew Tate <a href="https://twitter.com/Cobratate/status/1790802144431378828">claimed</a> putting $100 million in Bitcoin and exiting fiat completely.  </li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38847297/vanguard-appoints-former-blackrock-executive-salim-ramji-as-new-ceo">Vanguard Appoints Former BlackRock Executive Salim Ramji As New CEO</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38846834/bitcoin-boom-sparks-surge-in-crypto-wallet-recovery-services-its-just-pure-economics">Bitcoin Boom Sparks Surge In Crypto Wallet Recovery Services: &#8216;It&#8217;s Just Pure Economics&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38847206/crypto-stablecoin-issuer-circle-to-relocate-to-us-amid-market-rebound">Crypto Stablecoin Issuer Circle To Relocate To US Amid Market Rebound</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Sei (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SEI</a>)</td>
<td>$0.5428</td>
<td>+18.9%</td>
</tr>
<tr>
<td>Immutable (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>)</td>
<td>$2.42</td>
<td>+18.5%</td>
</tr>
<tr>
<td>Beam (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/beam/usd">BEAM</a>)</td>
<td>$0.02478</td>
<td>+16%</td>
</tr>
</tbody>
</table>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38852191/this-trader-sees-a-barbell-portfolio-of-btc-and-memes-as-most-profitable-trading-strategy">This Trader Sees A &#8216;Barbell Portfolio Of BTC And Memes&#8217; As Most Profitable Trading Strategy</a>
Analyst Notes: Crypto and stock trader Jelle <a href="https://twitter.com/CryptoJelleNL/status/1790807507977269561">noted</a> that Bitcoin should hold $65,000 for support and "I could see this playing out completely."
Part-time researcher Bitcoin Ape <a href="https://twitter.com/bitcoinape_/status/1790801761722135024">tweeted</a> an inverse head and shoulders pattern on Bitcoin's four-hour chart, saying this points to "imminent bullish price action."
Another full-time trader, Scient, is optimisticabout Bitcoin, noting the consolidation above $65,500 as a key level and for fresh entries. He awaits price action to develop some support above the $65,500 zone and "not FOMO here."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>, So far so good. Now, my ideal scenario would be; &#8211; 1D close above $65.5k &#8211; Take supply from the OB at $67k &#8211; Retest the $64.5-65.5k zone and successfully flip it to support for a continuation higher. A clean break of the local 4H downtrend is a good start. Consolidation… <a href="https://t.co/lSHFQ1Ngv8">https://t.co/lSHFQ1Ngv8</a> <a href="https://t.co/36CwVjEAG2">pic.twitter.com/36CwVjEAG2</a>
&mdash; Scient (@Crypto_Scient) <a href="https://twitter.com/Crypto_Scient/status/1790821932868452639?ref_src=twsrc%5Etfw">May 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38854828/veteran-trader-donalt-signals-potential-cycle-top-says-its-over-for-memes">Veteran Trader DonAlt Signals Potential &#8216;Cycle Top&#8217;, Says &#8216;It&#8217;s Over For Memes&#8217;</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BEAM

$BTC

$DOGE

$ETH

$IMX

$SEI

$SHIB

$SOL

Bitcoin, Ethereum, Dogecoin Spike On Good Macro News: 'So Far, So Good,' Says Bullish Trader

Guidance

AIRI

Air Industries Group Sees FY24 Net Sales At Least $50M Vs $53M Est.

AQMS

Aqua Metals Announces Circular Supply Chain Strategy With Sierra ARC Buildout, Advancing Commercial Partnerships, And $40M Capital Infusion

Mereo BioPharma Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MREO#NASDAQ">MREO</a>) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.03 by 133.33 percent.

MREO

Mereo BioPharma Group Q1 2024 Adj EPS $(0.01)

Air Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIRI#AMEX">AIRI</a>) reported quarterly losses of $(0.21) per share. The company reported quarterly sales of $14.06 million which beat the analyst consensus estimate of $13.00 million by 8.16 percent. This is a 12.05 percent increase over sales of $12.55 million the same period last year.

Earnings Beats

Air Industries Q1 2024 GAAP EPS $(0.21), Sales $14.06M Beat $13.00M Estimate

This contract extension represents approximately&nbsp;$350 million&nbsp;dollars&nbsp;of additional backlog, excluding any managed pressure drilling services, and replaces the one-year priced option that was agreed in&nbsp;May 2023. Anadarko retains three one-year unpriced options.

Contracts

Diamond Offshore Drilling Inks Two-year Contract Extension With Anadarko Petroleum In US Gulf Of Mexico For Ocean BlackHawk, Commencing In November 2024

Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) reported financial results for the third quarter of fiscal 2024 after the market close on Wednesday. Here&#8217;s a look at the <a href="https://www.benzinga.com/pressreleases/24/05/n38856163/cisco-reports-third-quarter-earnings">key metrics from the quarter</a>.
Q3 Earnings: Cisco&#8217;s third-quarter revenue decreased 13% year-over-year to $12.7 billion, which beat the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $12.531 billion, according to&nbsp;<a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported quarterly earnings of 88 cents per share, which beat analyst estimates of 82 cents per share.
Total subscription revenue came in at $6.9 billion. Total annualized recurring revenue came in at $29.2 billion, up 22% year-over-year. Cisco noted that its Splunk acquisition contributed $413 million to total revenue in the quarter.
&#8220;We delivered a solid&nbsp;Q3&nbsp;performance in what remains a dynamic environment. Our unique ability to bring together networking, security, observability, and data enables Cisco to offer our customers unrivaled digital resilience for the AI era,&#8221; said&nbsp;Chuck Robbins, chair and CEO of Cisco. 
Management Update: Cisco announced that it has named Splunk chief Gary Steele president&nbsp;of Go-to-Market, effective immediately. The company also announced that Jeff Sharritts, Cisco&#8217;s chief customer and partner officer, will depart the company after 24 years. Sharritts will remain with Cisco until mid-July to help with the transition. 
Outlook: Cisco expects&nbsp;fiscal fourth-quarter revenue to be between $13.4 billion and $13.6 billion versus estimates of $13.23 billion.&nbsp;Cisco sees fourth-quarter&nbsp;adjusted earnings in the range of 84 cents to 86 cents per share versus estimates of 85 cents per share.
Cisco also guided for full-year revenue of $53.6 billion to $53.8 billion versus estimates of $53.14 billion. The company sees full-year adjusted earnings in the range of $3.69 to $3.71 per share versus estimates of $3.67 per share.
&#8220;Customers are consuming the equipment shipped over the last few quarters in line with our expectations and we are seeing stabilization of demand as a result. The addition of Splunk to our product line will be a catalyst for further growth,&#8221; said&nbsp;Scott Herren, CFO of Cisco. 
Management will hold a conference call to discuss these results at 4:30 p.m. ET.
Don&#8217;t Miss: <a href="https://www.benzinga.com/news/earnings/24/05/38839147/wall-street-futures-pause-as-april-inflation-worries-eclipse-meme-stock-mania-2-0-why-this-analyst-">Wall Street Futures Pause As April Inflation Worries Eclipse Meme Stock Mania 2.0: Why This Analyst Bets May Will Be &#8216;Strong Month&#8217;</a>
CSCO Price Action:&nbsp;<a href="https://www.benzinga.com/quote/CSCO">Cisco shares</a> closed Wednesday up 1.47%. The stock was up another 5.29% after hours at $52.33 at the time of publication, according to&nbsp;<a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Anucha Cheechang from Shutterstock.

Movers

CSCO

Cisco Q3 Earnings: Revenue Beat, EPS Beat, Splunk Tailwinds, 'Stabilization Of Demand' And More

Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate of $(0.20) by 1040 percent. The company reported quarterly sales of $8.46 million which beat the analyst consensus estimate of $6.30 million by 34.33 percent. This is a 67.44 percent decrease over sales of $25.99 million the same period last year.

CDTX

Cidara Therapeutics Q1 2024 GAAP EPS $(2.28) Misses $(0.20) Estimate, Sales $8.46M Beat $6.30M Estimate

Remains on track towards accelerating development of its late-stage product candidate in the multi-billion-dollar pediatric progressive myopia market, MicroPine &nbsp;
Preparing for a 3Q 2024 launch of the first new ophthalmic steroid in 15 years, clobetasol propionate ophthalmic suspension 0.05%, for the treatment of inflammation and pain following ocular surgery
Company to host conference call and webcast today, May 15th, at 4:30 pm ET

Biotech

EYEN

Eyenovia Provides Updates On Its Myopia Phase III Program And Its 2 FDA Approved Commercial Products, Mydcombi And Clobetasol

Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate of $(1.48) by 54.05 percent.

PBLA

Panbela Therapeutics Q1 2024 GAAP EPS $(2.28) Misses $(1.48) Estimate

Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) reported quarterly losses of $(2.49) per share which missed the analyst consensus estimate of $(1.35) by 84.44 percent. This is a 76.73 percent increase over losses of $(10.70) per share from the same period last year. The company reported quarterly sales of $1.859 million which missed the analyst consensus estimate of $2.360 million by 21.23 percent. This is a 1.54 percent decrease over sales of $1.888 million the same period last year.

AVGR

Avinger Q1 2024 GAAP EPS $(2.49) Misses $(1.35) Estimate, Sales $1.859M Miss $2.360M Estimate

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts &nbsp;
Favorable clinical safety and tolerability profile observed with no dose limiting toxicities and no evidence of CRS-associated cytokines observed at any dose level
Cleared fifth of six monotherapy cohorts and second of four combination cohorts
Kineta is actively exploring strategic alternatives to maximize value for all stakeholders
Received $500,000 investment from an existing investor

Kineta Provides Update On Its Ongoing Phase 1/2 VISTA-101 Clinical Trial And Corporate Activities; Received $500,000 Investment From An Existing Investor

Kineta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.21) by 323.81 percent. This is a 15.58 percent decrease over losses of $(0.77) per share from the same period last year.

Kineta Q1 EPS $(0.89) Misses $(0.21) Estimate

BRK/A

PARA

Berkshire Hathaway Cuts Stake In Paramount Global By 55.79M Shares

Kodiak Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(1.07) by 23.36 percent.

Kodiak Sciences Q1 2024 GAAP EPS $(0.82) Beats $(1.07) Estimate

Stock Split

GCTK

Glucotrack Plans 1-For-5 Reverse Stock Split To Become Effective As Of The Opening Of Trading On May 20, 2024

Nano Magic (NMGX) has released an update to notify the public and investors about an entry into a material definitive agreement. Tom J. Berman, the...

Nano Magic CEO Employment Agreement Extended

Nano Magic (NMGX) has provided an announcement. On April 24, 2024, the Company celebrated significant advancements in brand growth and the successf...